IRIS Accounts Production v24.3.2.46 02128910 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh021289102023-08-31021289102024-08-31021289102023-09-012024-08-31021289102022-08-31021289102022-09-012023-08-31021289102023-08-3102128910ns15:EnglandWales2023-09-012024-08-3102128910ns14:PoundSterling2023-09-012024-08-3102128910ns10:Director12023-09-012024-08-3102128910ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3102128910ns10:SmallEntities2023-09-012024-08-3102128910ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3102128910ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3102128910ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3102128910ns10:AbridgedAccounts2023-09-012024-08-3102128910ns10:Director22023-09-012024-08-3102128910ns10:CompanySecretary12023-09-012024-08-3102128910ns10:RegisteredOffice2023-09-012024-08-3102128910ns5:CurrentFinancialInstruments2024-08-3102128910ns5:CurrentFinancialInstruments2023-08-3102128910ns5:ShareCapital2024-08-3102128910ns5:ShareCapital2023-08-3102128910ns5:RetainedEarningsAccumulatedLosses2024-08-3102128910ns5:RetainedEarningsAccumulatedLosses2023-08-3102128910ns5:FurnitureFittings2023-09-012024-08-3102128910ns5:MotorVehicles2023-09-012024-08-3102128910ns5:ComputerEquipment2023-09-012024-08-31
REGISTERED NUMBER: 02128910 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2024

FOR

JACASH LIMITED
TRADING AS
SAXON WARRIOR PHARMACY

JACASH LIMITED (REGISTERED NUMBER: 02128910)
TRADING AS SAXON WARRIOR PHARMACY






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 August 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


JACASH LIMITED
TRADING AS SAXON WARRIOR PHARMACY

COMPANY INFORMATION
for the year ended 31 August 2024







DIRECTORS: Mr B N Patel
Mrs G B Patel





SECRETARY: Mrs G B Patel





REGISTERED OFFICE: Saxon Warrior Pharmacy
The Square
Lenham
Maidstone
Kent
ME17 2QD





REGISTERED NUMBER: 02128910 (England and Wales)





ACCOUNTANTS: Raffingers Holdings Limited
Chartered Accountants
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD

JACASH LIMITED (REGISTERED NUMBER: 02128910)
TRADING AS SAXON WARRIOR PHARMACY

ABRIDGED BALANCE SHEET
31 August 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 67,490 85,268

CURRENT ASSETS
Stocks 25,125 30,525
Debtors 1,468 -
Cash at bank and in hand 156,430 161,334
183,023 191,859
CREDITORS
Amounts falling due within one year 117,296 147,627
NET CURRENT ASSETS 65,727 44,232
TOTAL ASSETS LESS CURRENT
LIABILITIES

133,217

129,500

CAPITAL AND RESERVES
Called up share capital 10,000 10,000
Retained earnings 123,217 119,500
133,217 129,500

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JACASH LIMITED (REGISTERED NUMBER: 02128910)
TRADING AS SAXON WARRIOR PHARMACY

ABRIDGED BALANCE SHEET - continued
31 August 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 August 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 April 2025 and were signed on its behalf by:





Mr B N Patel - Director


JACASH LIMITED (REGISTERED NUMBER: 02128910)
TRADING AS SAXON WARRIOR PHARMACY

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 August 2024

1. STATUTORY INFORMATION

Jacash Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

JACASH LIMITED (REGISTERED NUMBER: 02128910)
TRADING AS SAXON WARRIOR PHARMACY

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 August 2024

2. ACCOUNTING POLICIES - continued

Short term debtors and short term creditors
Short term debtors and short term creditors with no stated interest rate are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transactions costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 6 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 September 2023 259,266
Additions 2,374
At 31 August 2024 261,640
DEPRECIATION
At 1 September 2023 173,998
Charge for year 20,152
At 31 August 2024 194,150
NET BOOK VALUE
At 31 August 2024 67,490
At 31 August 2023 85,268

5. RELATED PARTY DISCLOSURES

At the balance sheet date, the company owed £19 (2024 - £41,922) to the directors.